Harbour Investments’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
Other funds holding ARKG
Harbour Investments's ARKG Position: Q1 2026 in Review
Harbour Investments increased its ARK Genomic Revolution ETF (ARKG) stake by 35% in Q1 2026, buying an estimated $21.7K and bringing the position to 2,835 shares worth $74.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2112.
Harbour Investments first reported a position in ARKG in Q1 2021 and has held it in 20 quarters since. The position peaked at $2.14M in Q2 2021. 218 funds tracked by Wall St. Rank hold ARKG as of Q1 2026.
- Harbour Investments held 2,835 shares of ARK Genomic Revolution ETF worth $74.9K as of Q1 2026.
- Harbour Investments bought 741 ARK Genomic Revolution ETF shares in Q1 2026, an estimated $21.7K.
- ARK Genomic Revolution ETF made up ﹤0.01% of Harbour Investments's portfolio in Q1 2026, its #2112 holding.
- Harbour Investments first reported a position in ARK Genomic Revolution ETF in Q1 2021 and has held it in 20 quarters since.
- Harbour Investments's ARK Genomic Revolution ETF position peaked at $2.14M in Q2 2021.
- 218 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2026.
Based on Harbour Investments's 13F filing for Q1 2026, filed 15 May 2026.